Molecular Partners AG (MOLN)
5.08
-0.14
(-2.68%)
USD |
NASDAQ |
Dec 20, 16:00
5.18
+0.10
(+1.97%)
After-Hours: 20:00
Molecular Partners Total Liabilities (Quarterly): 18.34M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 135.61M |
| CRISPR Therapeutics AG | 316.47M |
| Addex Therapeutics Ltd | 1.315M |
| NLS Pharmaceutics Ltd | 10.46M |
| MoonLake Immunotherapeutics | 22.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.31M |
| Shareholders Equity (Quarterly) | 164.96M |
| Current Ratio | 14.33 |